Long-term prognostic value of ST-segment resolution in patients treated with fibrinolysis or primary percutaneous coronary intervention results from the DANAMI-2 (DANish trial in acute myocardial infarction-2)
- PMID: 19874989
- DOI: 10.1016/j.jacc.2009.03.084
Long-term prognostic value of ST-segment resolution in patients treated with fibrinolysis or primary percutaneous coronary intervention results from the DANAMI-2 (DANish trial in acute myocardial infarction-2)
Abstract
Objectives: The purpose of this study was to determine the prognostic value of ST-segment resolution after primary percutaneous coronary intervention (pPCI) versus fibrinolysis.
Background: Resolution of the ST-segment has been used as a surrogate end point in trials evaluating reperfusion in acute myocardial infarction; however, its prognostic significance may be limited to patients treated with fibrinolysis.
Methods: In the DANAMI-2 (DANish trial in Acute Myocardial Infarction-2) substudy, including 1,421 patients, the ST-segment elevation at baseline, pre-intervention, 90 min, and 4 h was assessed. The ST-segment resolution was grouped as follows: 1) complete > or =70%; 2) partial 30% to <70%; and 3) no resolution <30%. End points were 30-day and long-term mortality and reinfarction.
Results: The ST-segment resolution at 90 min was more pronounced after pPCI (median 60% vs. 45%, p < 0.0001), and a catch-up phenomenon was observed at 4 h. In the fibrinolysis group, 30-day and long-term mortality rates were significantly higher among patients without ST-segment resolution, whereas reinfarction rates were higher with complete ST-segment resolution. The ST-segment resolution was not associated with the 2 end points in the pPCI group. By multivariate analysis, ST-segment resolution at 4 h was an independent predictor of lower mortality, but higher reinfarction rates among patients receiving fibrinolytic therapy.
Conclusions: The ST-segment resolution at 90 min was more complete after pPCI, suggesting better epicardial and microvascular reperfusion, whereas no difference between treatment strategies was seen at 4 h. The ST-segment resolution at 4 h correlated with decreased mortality, but increased reinfarction rates among patients receiving fibrinolytic therapy, whereas no association was seen for patients receiving pPCI. Consequently, 4-h ST-segment resolution remains an important prognosticator after fibrinolysis, but may be overemphasized as a surrogate end point after pPCI.
Comment in
-
ST-segment resolution and outcome in myocardial infarction.J Am Coll Cardiol. 2010 Apr 13;55(15):1646-7; author reply 1647. doi: 10.1016/j.jacc.2009.12.033. J Am Coll Cardiol. 2010. PMID: 20378090 No abstract available.
Similar articles
-
Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.Am J Cardiol. 2010 Jun 1;105(11):1528-34. doi: 10.1016/j.amjcard.2010.01.005. Epub 2010 Apr 14. Am J Cardiol. 2010. PMID: 20494656 Clinical Trial.
-
Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy).Am J Cardiol. 2005 Dec 1;96(11):1469-75. doi: 10.1016/j.amjcard.2005.07.053. Epub 2005 Oct 11. Am J Cardiol. 2005. PMID: 16310424 Clinical Trial.
-
Usefulness of quantitative baseline ST-segment elevation for predicting outcomes after primary coronary angioplasty or fibrinolysis (results from the DANAMI-2 trial).Am J Cardiol. 2006 Mar 1;97(5):611-6. doi: 10.1016/j.amjcard.2005.09.099. Epub 2006 Jan 6. Am J Cardiol. 2006. PMID: 16490423
-
Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials.Ann Emerg Med. 2008 Dec;52(6):665-76. doi: 10.1016/j.annemergmed.2008.08.033. Ann Emerg Med. 2008. PMID: 19027496 Review.
-
Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis.Eur Heart J. 2010 Sep;31(17):2156-69. doi: 10.1093/eurheartj/ehq204. Epub 2010 Jul 2. Eur Heart J. 2010. PMID: 20601393 Review.
Cited by
-
Is door-to-balloon time the best metric to assess successful treatment of STEMI?Clin Cardiol. 2011 Jul;34(7):408-9. doi: 10.1002/clc.20911. Epub 2011 Jun 9. Clin Cardiol. 2011. PMID: 21660992 Free PMC article.
-
Role of ST-Segment Resolution Alone and in Combination With TIMI Flow After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction.J Am Heart Assoc. 2023 Jul 18;12(14):e029670. doi: 10.1161/JAHA.123.029670. Epub 2023 Jul 14. J Am Heart Assoc. 2023. PMID: 37449560 Free PMC article. Clinical Trial.
-
Accuracy of Post-thrombolysis ST-segment Reduction as an Adequate Reperfusion Predictor in the Pharmaco-Invasive Approach.Arq Bras Cardiol. 2021 Jul;117(1):15-25. doi: 10.36660/abc.20200241. Arq Bras Cardiol. 2021. PMID: 34320062 Free PMC article. English, Portuguese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical